Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
End price
05.10.24
-
Summary
This prediction is currently being closed. Wedbush's BUY prediction for Freeline Therapeutics Holdings plc ADR is currently unchanged. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat
In the thread Trading Freeline Therapeutics Holdings plc ADR
Die von Wedbush gewählte maximale Laufzeit wurde überschritten